Correlative Light Electron Ion Microscopy reveal in vivo localisation of bedaquiline in Mycobacterium tuberculosis infected lungs

Antony Fearns, Daniel J. Greenwood, Angela Rodgers, Haibo Jiang, Maximiliano G. GutiérrezbioRxiv 2020 · DOI

TL;DR

This paper introduces a novel correlative imaging technique, CLEIMiT, to visualize the subcellular distribution of the anti-tuberculosis drug bedaquiline within infected lung tissue. They discovered that bedaquiline accumulates not only in foamy macrophages, as expected, but also significantly in polymorphonuclear cells (PMNs), revealing new potential drug reservoirs.

What Problem Does This Paper Address?

Treating tuberculosis (TB) requires long, multi-drug regimens, partly because we don't fully understand how antibiotics reach and distribute within the complex tissue environments of TB lesions. Specifically, visualizing the precise subcellular location of drugs within infected cells in living tissue at high resolution has been a major challenge. Existing methods either lack subcellular resolution (like MALDI-MSI) or struggle to correlate drug localization with detailed cellular and tissue context (like nanoSIMS alone). This gap hinders our ability to optimize drug delivery and treatment strategies.

Methods

The core innovation is CLEIMiT (Correlative Light Electron Ion Microscopy in Tissue). This multimodal approach integrates:

  • Micro Computed Tomography (µCT): Used for initial 3D visualization of lung lesions and to guide subsequent sectioning.
  • Fluorescence Microscopy: To identify infected cells (Mtb expressing E2-Crimson) and lipid-rich foamy macrophages (using BODIPY staining).
  • Scanning Electron Microscopy (SEM): To provide high-resolution ultrastructural detail of the tissue and cells.
  • Nanoscale Secondary Ion Mass Spectrometry (nanoSIMS): To map the elemental distribution of the drug (bedaquiline, detected via its bromine atom, 79Br) and cellular components (like carbon for morphology, phosphorus for nucleic acids, and sulfur for lipids).

The key to CLEIMiT is a meticulous workflow for sectioning, embedding, and aligning data from these disparate imaging modalities. This allows for precise correlation of drug signals with specific cellular structures and organelles within the same tissue sample.

Datasets

Not discussed in the paper. The study uses a mouse model of tuberculosis infection and analyzes tissue samples from these mice.

Key Insights and Ideas

  • Bridging the Resolution Gap: CLEIMiT successfully bridges the gap between organelle-level drug localization and the complex, in vivo tissue environment.
  • Beyond Macrophages: The study reveals that bedaquiline doesn't just reside in foamy macrophages; it also shows significant accumulation in polymorphonuclear cells (PMNs). This is a crucial finding as PMNs are a different cell type with distinct roles and metabolic properties.
  • Heterogeneous Drug Distribution: Bedaquiline distribution within both foamy macrophages and bacteria is heterogeneous, meaning not all bacteria or lipid droplets receive the same drug concentration. This could explain why some bacteria persist despite treatment.
  • PMN Granules and Cytosol: In PMNs, bedaquiline was found not only within granules but also in the cytosol, suggesting different mechanisms of uptake or retention compared to macrophages.

Key Results

  • CLEIMiT was successfully developed and applied to visualize bedaquiline localization in Mycobacterium tuberculosis-infected mouse lungs.
  • Bedaquiline was found to accumulate in lipid droplets (LDs) within foamy macrophages, consistent with its lipophilic nature.
  • Significantly, bedaquiline was also found to accumulate in polymorphonuclear cells (PMNs), which are recruited to the granulomatous lesions.
  • Quantitative analysis showed that bedaquiline distribution was heterogeneous, with some intracellular bacteria and lipid droplets showing higher drug concentrations than others.
  • The study provides detailed correlative images showing the co-localization of bedaquiline with Mtb and within different cellular compartments of foamy macrophages and PMNs.

Limitations and Future Work

  • Detection Limits: The paper acknowledges that the detection limits of nanoSIMS for various elements and isotopes are not always well-documented in biological systems, which could influence the sensitivity of drug detection.
  • PMN Dynamics: The authors suggest that further work should investigate when and how PMNs internalize antibiotics, given their motile nature and recruitment during inflammation.
  • Broader Applicability: CLEIMiT is presented as a versatile technique applicable to other drugs (not just bromine-containing ones) and potentially other biological systems. Future work could involve using stable isotope-labeled drugs to expand its utility.
  • Cell-Type Specificity: The authors propose using transgenic mice with specific fluorescent markers to further define the preferential distribution of antibiotics in various cell subtypes.
  • Clinical Relevance: The study used a physiologically relevant dose of bedaquiline, but further studies could explore the impact of different doses and treatment durations on drug distribution.

Summary updated

Abstract

Abstract Correlative light, electron and ion microscopy (CLEIM) offers huge potential to track the intracellular fate of antibiotics, with organelle-level resolution. However, a correlative approach that enables subcellular antibiotic visualisation in pathogen-infected tissue is lacking. Here, we developed CLEIM in tissue (CLEIMiT), and used it to identify the cell-type specific accumulation of an antibiotic in lung lesions of mice infected with Mycobacterium tuberculosis. Using CLEIMiT, we found that the anti-TB drug bedaquiline is localised not only in foamy macrophages in the lungs during infection but also accumulate in polymorphonuclear (PMN) cells.
BibTeX
@misc{fearns2020correlative,
  author = {Antony Fearns and Daniel J. Greenwood and Angela Rodgers and Haibo Jiang and Maximiliano G. Gutiérrez},
  title = {{Correlative Light Electron Ion Microscopy reveal <i>in vivo</i> localisation of bedaquiline in <i>Mycobacterium tuberculosis</i> infected lungs}},
  year = {2020},
  doi = {10.1101/2020.08.05.237537},
  howpublished = {bioRxiv},
}

Loading related content...

Figure